GS Finance Corp. Files 424B2 Prospectus for New Securities Offering
| Field | Detail |
|---|---|
| Company | Gs Finance Corp. |
| Form Type | 424B2 |
| Filed Date | Mar 24, 2026 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 20 min |
| Key Dollar Amounts | $1,000, $1,243, $1,486, $900, $930 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: prospectus, capital-raise, debt, equity
Related Tickers: GS
TL;DR
**GS Finance Corp. is prepping a new securities offering; watch for details on what they're selling.**
AI Summary
GS Finance Corp. filed a 424B2 prospectus on March 24, 2026, detailing an offering under their registration statement 333-284538-03. This filing indicates that GS Finance Corp., a subsidiary of Goldman Sachs Group Inc., is preparing to offer new securities. For investors, this means potential dilution if new shares are issued, but also new investment opportunities in debt or equity instruments from a major financial institution.
Why It Matters
This filing signals GS Finance Corp. is gearing up to raise capital, which could impact the company's financial structure and future growth prospects.
Risk Assessment
Risk Level: medium — The risk is medium because while it's a standard filing for capital raising, the specific terms of the offering (not yet detailed) could introduce new risks or opportunities.
Analyst Insight
Investors should monitor subsequent filings from GS Finance Corp. for specific details on the type, amount, and terms of the securities being offered, as this will determine the actual impact on the stock.
Key Players & Entities
- GS Finance Corp. (company) — the filer of the 424B2 prospectus
- Goldman Sachs Group Inc. (company) — parent company of GS Finance Corp.
- March 24, 2026 (date) — filing date of the 424B2 prospectus
- 333-284538-03 (string) — file number for the registration statement
FAQ
What is the purpose of this 424B2 filing by GS Finance Corp.?
The 424B2 filing by GS Finance Corp. on March 24, 2026, is a prospectus supplement related to a previously filed registration statement (File No. 333-284538-03), indicating that the company is preparing to offer new securities to raise capital.
Who is the parent company of GS Finance Corp.?
The parent company of GS Finance Corp. (CIK: 0001419828) is The Goldman Sachs Group, Inc. (CIK: 0000886982), as indicated in the filing details.
Filing Stats: 4,929 words · 20 min read · ~16 pages · Grade level 16.8 · Accepted 2026-03-24 12:24:47
Key Financial Figures
- $1,000 — expected to be April 14, 2027) for each $1,000 face amount of your notes equal to at l
- $1,243 — amount of your notes equal to at least $1,243 (set on the trade date). If your note
- $1,486 — (i) the threshold settlement amount of $1,486 for each $1,000 face amount of your not
- $900 — he trade date is expected to be between $900 and $930 per $1,000 face amount. For a
- $930 — date is expected to be between $900 and $930 per $1,000 face amount. For a discussio
- $10,000 — trade date Authorized denominations: $10,000 or any integral multiple of $1,000 in e
Filing Documents
- nvdac247_prelim.htm (424B2) — 451KB
- img253098389_0.jpg (GRAPHIC) — 6KB
- img253098389_1.jpg (GRAPHIC) — 50KB
- img253098389_2.jpg (GRAPHIC) — 6KB
- 0001193125-26-121223.txt ( ) — 540KB
From the Filing
424B2 Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-284538 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. GS Finance Corp. $ Autocallable Buffered Equity-Linked Notes due guaranteed by The Goldman Sachs Group, Inc. The notes do not bear interest. The notes will mature on the stated maturity date (expected to be March 30, 2028) unless they are automatically called on the call observation date (expected to be April 9, 2027). Your notes will be automatically called on the call observation date if the closing price of the common stock of NVIDIA Corporation on such date is greater than or equal to the initial index stock price (set on the trade date (expected to be March 27, 2026) and will be an intra-day price or the closing price of one share of the index stock on the trade date), resulting in a payment on the call payment date (expected to be April 14, 2027) for each $1,000 face amount of your notes equal to at least $1,243 (set on the trade date). If your notes are not automatically called, the amount that you will be paid on your notes on the stated maturity date will be based on the performance of the index stock as measured from the trade date to and including the determination date (expected to be March 27, 2028). If the final index stock price on the determination date is greater than or equal to the initial index stock price, the return on your notes will be positive and you will receive the greater of (i) the threshold settlement amount of $1,486 for each $1,000 face amount of your notes and (ii) the sum of (a) the $1,000 face amount plus (b) the product of (1) $1,000 times (2) the index stock return. The index stock return is the percentage increase or decrease in the final index stock price from the initial index stock price. If the final index stock price declines by up to 20% from the initial index stock price, you will receive the face amount of your notes. If the final index stock price declines by more than 20% from the initial index stock price, the return on your notes will be negative and you will lose 1.25% of the face amount of your notes for every 1% that the final index stock price has declined below 80% of the initial index stock price. See page S- 3 . You could lose your entire investment in the notes. If your notes are not automatically called on the call observation date, we will determine your payment at maturity by calculating the index stock return, which is the percentage increase or decrease in the final index stock price from the initial index stock price. At maturity, for each $1,000 face amount of your notes, you will receive an amount in cash equal to: • if the index stock return is positive or zero (the final index stock price is greater than or equal to the initial index stock price), the greater of (i) the threshold settlement amount and (ii) the sum of (a) $1,000 plus (b) the product of (1) $1,000 times (2) the index stock return; • if the index stock return is negative but not below -20% (the final index stock price is less than the initial index stock price, but not by more than 20%), $1,000; or • if the index stock return is negative and is below -20% (the final index stock price is less than the initial index stock price by more than 20%), the sum of (i) $1,000 plus (ii) the product of (a) $1,000 times (b) the buffer rate of 125% (see page S- 3 ) times (c) the sum of the index stock return plus 20%. You will receive less than the face amount of your notes. You should read the disclosure herein to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc. See page S- 18 . The estimated value of your notes at the time the terms of your notes are set on the trade date is expected to be between $900 and $930 per $1,000 face amount. For a discussion of the estimated value and the price at which Goldman Sachs & Co. LLC would initially buy or sell your notes, if it makes a market in the notes, see the following page. Original issue date: expected to be April 1, 2026 Original issue price: 100% of the face amount 1 Underwriting discount: % of the face amount 1, 2 Net proceeds to the issuer: % of the face amount 1 Accounts of certain national banks, acting as purchase agents for such accounts, have agreed with the purchase agents to pay a purchase price of % of the face amount, and as a result of such agreements, the agents with respect to sales to be made to such accounts will not receive any portion of the underwriting discount. 2 This includes a selling concession of up to 1.5%. Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of